Rai Varnika, Saha Anurag, Mehta Shailee, Shah Rujuta Ankit, Trivedi Priti, Samanta Satarupa T, Rathod Priyank, Manimaran Poornima
Onco-Pathology Department, Gujarat Cancer and Research Institute, Ahmedabad, India.
Department of Surgical Oncology, Gujarat Cancer Research Institute, Ahmedabad, India.
Eur Arch Otorhinolaryngol. 2024 Mar;281(3):1571-1579. doi: 10.1007/s00405-023-08341-x. Epub 2023 Nov 27.
Medullary carcinoma (MTC) is a rare neuroendocrine thyroid neoplasm. The international medullary thyroid carcinoma grading scheme (IMTCGS), which has prognostic significance, has been introduced recently. The present study graded MTC cases using the IMTCGS and evaluated it in our study cohort.
All MTC thyroidectomy cases over 6 years were evaluated. Low-grade (LG) and high-grade (HG) were compared. Survival analysis included overall survival (OS), loco-regional free survival and distant metastasis free survival (DMFS).
Of 32 cases, 31.25% were HG and 68.75% LG. The mean age was 44.0 years and M:F ratio 1:1.146. HG patients were older and had tumour cells with high-grade nuclear features and prominent nucleoli and showed distant metastasis. Necrosis was found more in patients with high grade nuclear features. There was discordance between the high Ki67 (60%) and increased mitotic activity (20%). Univariate survival analysis revealed poor DMFRS and OS in the cohorts with high grade, Ki67 > 5% and coagulative necrosis. The multivariate cox regression analysis showed IMTCGS significantly associated with overall survival (HR 28.30, p = 0.009) and DMFS (HR 15.70, p = 0.02).
This is the first Indian study evaluating IMTCGS, a very simple and convenient grading system that can be readily used in any tertiary health care centre. IHC for Ki 67 should mandatorily be done irrespective of the low mitotic activity on the HPE and necrosis should be diligently searched in cases with high-grade nuclear morphology. HG MTC cohorts were associated with poor OS as well as DMFRS.
髓样癌(MTC)是一种罕见的神经内分泌性甲状腺肿瘤。最近引入了具有预后意义的国际甲状腺髓样癌分级方案(IMTCGS)。本研究使用IMTCGS对MTC病例进行分级,并在我们的研究队列中对其进行评估。
对6年以上的所有MTC甲状腺切除病例进行评估。比较低级别(LG)和高级别(HG)病例。生存分析包括总生存期(OS)、局部区域无瘤生存期和远处转移无生存期(DMFS)。
32例病例中,31.25%为HG,68.75%为LG。平均年龄为44.0岁,男女比例为1:1.146。HG患者年龄较大,肿瘤细胞具有高级别核特征和明显核仁,并出现远处转移。在具有高级别核特征的患者中发现更多坏死。高Ki67(60%)与有丝分裂活性增加(20%)之间存在不一致。单因素生存分析显示,高级别、Ki67>5%和凝固性坏死的队列中DMFRS和OS较差。多因素cox回归分析显示,IMTCGS与总生存期(HR 28.30,p = 0.009)和DMFS(HR 15.70,p = 0.02)显著相关。
这是第一项评估IMTCGS的印度研究,IMTCGS是一种非常简单方便的分级系统,可在任何三级医疗保健中心轻松使用。无论苏木精-伊红染色切片(HPE)上有丝分裂活性如何,都应强制进行Ki 67免疫组化检测,对于具有高级别核形态的病例应仔细查找坏死情况。HG MTC队列与较差的OS以及DMFRS相关。